The number of coronavirus cases in the U.S. has passed three million. More than 128,000 people have died. Florida, Arizona and Texas, among other states, are experiencing acute surges in cases. (The Washington Post)

Walgreens has partnered with VillageMD to open as many as 700 primary care clinics. The goal is to open the clinics over the course of five years in areas that lack doctors and are medically underserved. (CNBC)

Biogen has submitted its Alzheimer’s drug aducanumab to the Food and Drug Administration for approval after a delay. The drugmaker has requested priority review for the application, which would result in a final decision in six months. (Endpoints)

Abbvie’s Botox rival may be facing a 10-year ban. A U.S. International Trade Commission judge’s ruling that Evolus and Daewoong’s treatment should be banned came after a complaint filed arguing the drugmakers’ stole trade secrets. A final decision will be rendered in November. (STAT)

Physicians are adjusting to COVID-era uncertainty, but they want support from pharma to more effectively communicate with patients. AbelsonTaylor and Veeva’s report “Managing Uncertainty: Helping Physicians Survive in the Short-Term and Thrive in the Long-Term” is based on a survey of 550 physicians. (MM&M)